ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    cabazitaxel prednisone custirsen
Previous Study | Return to List | Next Study

Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer (AFFINITY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01578655
Recruitment Status : Completed
First Posted : April 17, 2012
Last Update Posted : October 12, 2016
Sponsor:
Information provided by (Responsible Party):
Achieve Life Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2016
  Actual Study Completion Date : July 2016
  Certification/Extension First Submitted : October 7, 2016
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):